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Folding, assembly and stability of α-helical membrane proteins is still not very well understood. Several of these membrane proteins contain
cofactors, which are essential for their function and which can be involved in protein assembly and/or stabilization. The effect of heme binding on
the assembly and stability of the transmembrane b-type cytochrome b559′ was studied by fluorescence resonance energy transfer. Cytochrome b559′
consists of two monomers of a 44 amino acid long polypeptide, which contains one transmembrane domain. The synthesis of two variants of the
b559′ monomer, each carrying a specific fluorescent dye, allowed monitoring helix–helix interactions in micelles by resonance energy transfer. The
measurements demonstrate that the transmembrane peptides dimerize in detergent in the absence and presence of the heme cofactor. Cofactor
binding only marginally enhances dimerization and, apparently, the redox state of the heme group has no effect on dimerization.
© 2006 Elsevier B.V. All rights reserved.Keywords: Assembly; Cytochrome; Heme; Membrane protein folding; Two-stage model1. Introduction
Folding and stability of membrane proteins are still not well
understood and many open questions remain to be answered.
While in vivo large transmembrane channels are involved in in-
tegration of single α-helices or entire membrane proteins into a
membrane (for recent reviews see [1,2]), and the involvement of
lipids or transmembrane chaperones, like YidC, in membrane
protein folding is discussed [3–5], in vitro studies with several
membrane proteins have suggested that folding of α-helical
membrane proteins can be described by a simple two-stage model
[6,7]. In this model individual transmembrane helices integrate
separately into a membrane (stage I) and afterwards the individual
helices interact to form a higher ordered oligomer (stage II). This
simplified view allows discrimination between energetic contribu-Abbreviations: DDM, n-dodecyl-β-D-maltoside; FRET, Fluorescence Reso-
nanceEnergyTransfer;MalE,maltose binding protein; SDS, sodiumdodecylsulfate
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helix–helix interactions, and thus facilitates detailed studies of
transmembrane helix–helix interaction.
Using a few basic model proteins, several studies have char-
acterized the importance of single amino acids for the overall
stability of a helix oligomer in micelles as well as in biological
membranes.
As a paradigm for the second stage of the two-stage model,
dimerization of the human glycophorin A transmembrane region
has been studied extensively using different genetic, biochemical
and biophysical techniques [8–16]. The influence of cofactor
binding on membrane protein folding and stability was measured
using bacteriorhodopsin and retinal as a model system [17–20],
followed by studies on a few other model proteins. In addition to
bacteriorhodopsin, mainly the plant light harvesting complex II
and the light harvesting complexes from purple bacteria have
been studied [21–31]. For bacteriorhodopsin it has been shown
that the protein forms a folding intermediate without the retinal
cofactor and adopts its final structure only upon cofactor bind-
ing [17,18,32]. Since the cofactor is buried within the core of the
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formation to allow incorporation and binding of retinal. In the
case of the plant light harvesting complex II formation of stable
secondary and tertiary structures is coupled with cofactor binding
[28,29,33].
Several transmembrane proteins involved in charge transfer
across membranes are b-type cytochromes and this class of pro-
teins binds one or more heme cofactors non-covalently [34].
Transmembrane b-type cytochromes can be found in larger trans-
membrane protein complexes such as the succinate dehydroge-
nase (complex II), cytochrome bc1 and b6f complexes, cytochrome
bd and bo3 complexes, as well as in photosystem II of higher plants
and cyanobacteria [35].
Cytochrome b559 is part of photosystem II and in vivo the
protein is a heterodimer between oneα- (PsbE) and oneβ-subunit
(PsbF), which together bind one heme group non-covalently [36].
All residues critical for dimerization of the peptides as well as for
heme binding are conserved in each individual subunit and,
indeed, a homodimeric cytochrome b559-like protein (cytochrome
b559′ ) can be reconstituted in vitro from solely the chemically
synthesized PsbF peptide and free heme [37]. Several detergents
have been tested for their ability to promote cytochrome
formation in vitro but only a mixture of SDS (or LDS) and
octylglycoside or Triton X-100 yielded a protein with an ab-
sorbance spectrum similar to native cytochrome b559 [37]. In
addition, a PsbF-MalE fusion protein can be used to reconstitute a
cytochrome b559-like protein in buffer containing only the non-
ionic detergent DDM [38].
The homodimeric cytochrome b559′ represents the simplest
transmembrane b-type cytochrome analyzed so far and can, there-
fore, serve asminimalmodel system to study the influence of heme
binding on folding and stability of transmembrane b-type cyto-
chromes. In the present study chemically synthesized PsbF pep-
tides in combination with fluorescence resonance energy transfer
was used to analyzed the effect of heme incorporation and of the
heme redox state on transmembrane helix–helix interactions.
2. Materials and methods
2.1. Peptide synthesis
The PsbF transmembrane peptide (sequence in single–letter code: MATQ-
NPNQPVTYPIFTVRWLAVHTLAVPSVFFVGAIAAMQFIQRCL) was synthe-
sized on an S-DVB (stryrene-divinylbenzene) resin carrying an OCH2-PAM linker
and using an in-situ neutralization protocol and HBTU activation for machine-
assisted Boc (tert-butoxycarbonyl) chemistry48. All amino acids were obtained
from Novabiochem. Solvents were purchased from Biosolve.
The peptide was deprotected and simultaneously cleaved from the resin
using anhydrous HF. Subsequently it was precipitated with ether, and the crude
product was dissolved in trifluoroethanol and subsequently diluted with three
parts water containing 0.1% trifluoroacetic acid (TFA), and lyophilized. The
peptide segment was purified by RP-HPLC on a C4-column from Vydac using a
linear gradient of solution B (60% isopropanol, 20% acetonitrile, 10% water
with TFA) in solution A (water with 0.1% TFA) at 60 °C. The elution of the
peptide was monitored at 214 nm. Fractions were analyzed by electrospray mass
spectrometry with a Thermo Finnigan LCQ mass spectrometer, and the product-
containing fractions were combined and lyophilized. The observed molecular
weight was 5148 Da (calculated MW: 5149 Da).
Purified PsbF peptides were labeled with either BODIPY 577/618
maleimide (Invitrogen) or DY-633 maleimide (Dyomics) in a buffer consistingof 8 M urea, 200 mM NaPi and 17 mg/ml dodecylphosphocholine (DPC) at pH
8.0 mixed with 20% trifluorethanol. 1.2 equivalents of each dye have been
dissolved in DMSO and used in labeling reactions. Fluorescently labeled PsbF
was purified by HPLC using the conditions described above. The molecular
weight of PsbF-BODIPY was found to be 5724 Da (calculated MW 5724 Da).
2.2. Fluorescence spectroscopy
All fluorescence spectra were measured on an Aminco Bowman Series II
fluorimeter with a slid width of 4 nm for the excitation and emission mono-
chromators. Samples were kept anaerobic with argon. Excitation and emission
wavelengths are indicated in the figure legends.
2.3. Expression, purification of the PsbF-MalE fusion protein and
analysis of dimerization
The psbF gene was amplified by PCR using genomic Synechocystis PCC
6803 DNA as a template and the gene was ligated to the expression vector pMal-
c2x (New England Biolabs) after restriction digestion of the PCR fragment and
the vector with BamHI and HindIII. The sequence of the cloned DNA fragment
was confirmed by DNA sequencing.
Overexpression and purification of the PsbF-MalE fusion protein was done
as described in detail recently [38].
For reconstitution in the presence of heme, the PsbF fusion protein was mixed
with heme in a 2:1 ratio since cytochrome b559′ is a homodimer, which binds one
heme molecule. If indicated, SDS was added from a 0.5 M stock solution. For
reduction 10 mM sodium dithionite was added to the solution from a 1 M stock
solution. Samples were kept anaerobic with argon. Incorporation of heme and
assembly of the cytochromewas tested by UV/Vis spectroscopy on a Perkin Elmer
Lambda 35 instrument. Spectra were taken from 350 nm to 800 nm with a resolu-
tion of 0.5 nm. Commercially available hemine chloride (Sigma, Taufkirchen,
Germany) was dissolved in 50% ethanol and the heme was solubilized by addition
of NaOH. This heme solutionwas diluted fourfold into 50mMTris pH 8.0, 50mM
NaCl, 5 mM DDM buffer. The heme concentration was determined spectroscop-
ically using an extinction coefficient of ε385 nm=56 mM
−1 cm−1.
To assess the influence of heme binding and the heme redox state on the
thermodynamic stability of the PsbF dimer, about 5 mM PsbF-MalE fusion
protein in 50mMphosphate buffer pH 7.5, 50mMNaCl, 5mMDDMwasmixed
with 3.5 mM SDS. Samples were incubated for 2 h at room temperature and
glutaraldehydewas added to a final concentration of 25mM. Samples were either
incubated in the absence of heme, or in the presence of a two-fold excess of heme.
After addition of heme, the individual samples were kept free of oxygen by a
stream of argon, which was directed over the solutions. For oxidation, 2 mM
ferricyanide, for reduction 2 mM dithionite were added. Samples were incubated
for about 16 h and analyzed on SDS gels containing 6 M urea.
2.4. GALLEX-assay
In vivomeasurements of the homodimerization of the PsbF TM domain were
done using the GALLEX system [8]. The psbF gene was amplified by PCR and
ligated to the NheI/BamHI restriction digested plasmid pLM [8]. The correct
insertion of the gene was checked by DNA sequencing. Ligation of a gene to this
plasmid results in generation of an open reading frame, which encodes for a
chimeric protein with a N-terminal fusion to the LexA DNA binding domain and
a C-terminal fusion to the MalE domain. The resulting plasmid was transformed
into E. coli SU101 and the GALLEX measurement was done according to the
protocol published recently [8]. To introduce single point mutations into the
psbF gene the Quickchange mutagenesis kit was used according to the
manufacturer's instructions (Stratagene).
3. Results
3.1. Dimerization of the PsbF protein studied with fusion proteins
It has recently been shown that cytochrome b559′ assembles in
vitro as well as in vivo [38]. In order to study the dimerization of
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assay) [8], the psbF gene was expressed as a fusion to the DNA
binding domain of the E. coli LexA protein. Heterologously ex-
pressed PsbF integrates into the E. coli cytoplasmic membrane
and binds heme from the endogenous heme pool of E. coli [38].
Therefore, fusion of the PsbF protein to the LexA DNA binding
domain (LexA DBD) allows one to measure the interaction of the
PsbF transmembrane region within the membrane and, to study
the influence of single amino acid substitutions on the transmem-
brane helix interaction propensity. The GALLEX system was
designed to measure such homo- as well as hetero-oligomeric in-
teractions of transmembrane helices within the E. coli cytoplasmic
membrane [8]. Oligomerization of a transmembrane helix of inter-
est results in formation of a LexADBD dimer, which can bind to a
promoter/operator region. This promoter/operator, which is inte-
grated into the E. coli genome, controls the expression of a reporter
gene (lacZ) and the propensity of a transmembrane domain to
oligomerize can be measured by determining the activity of the
reporter β-galactosidase. In the GALLEX assay the reporter gene
activity is repressed if a transmembrane domain oligomerizes.
In Fig. 1A the oligomerization propensity of the wt PsbF
peptide is determined using the GALLEX assay. As controls, the
interaction of the wt glycophorin A transmembrane helix (strong
interaction) and the glycophorin A transmembrane helix with a
single amino acid substitution (G83I, very weak interaction) is
measured. Besides measuring the interaction tendency of wt
PsbF and PsbF H23A, the interaction of a PsbF variant G34I was
also measured, since this amino acid substitution highly disturbs
assembly of cytochrome b559′ [38]. The presented results repro-
duce the findings of a recent study [38] and demonstrate that
PsbF oligomerizes within the E. coli membrane, although to a
lesser extend than the glycophorin A transmembrane helix. In-
terestingly, after substitution of histidine 23, which is involved in
heme binding, by alanine no significant differences in interact-
ion propensity was observed (Fig. 1A). Since it has been shown
in vitro that such a substitution of this residue abolishes heme
binding completely [38], this observation indicates that hemeFig. 1. Homooligomerization of PsbF wt and mutated TM sequences measured with th
are shown. GpAwt and GpA G83I are used as internal controls to define a weak (G
chimeric proteins and the topology in the E. coli inner membrane are shown in [38].
MalE fusion protein in buffer with 5 mM DDM and 3.5 mM SDS was incubated for
addition of glutaraldehyde, samples were incubated for 16 h and separated on SDS ge
As a control PsbF-MalE was incubated in 250 mM SDS, which highly disrupt dimebinding does not affect dimerization of the PsbF peptide
significantly.
While the GALLEX assay allows measuring the interaction of
transmembrane helices in vivo, the heme redox state cannot be
controlled and thus a potential influence of the heme redox state
on cytochrome assembly cannot be measured. To study the effect
of the heme redox state on association of the PsbF peptide in vitro,
a PsbF-MalE fusion protein was used, which has been shown to
form stable dimers on SDS gels [38]. Although the protein forms
dimers under SDS-PAGE conditions, this approach does not
allow studying the influence of heme binding or the heme redox
state on dimerization since the non-covalently attached heme is
released during electrophoresis. To overcome this problem the
fusion protein was incubated in detergent in the absence of heme,
or in the presence of oxidized or reduced heme prior to electro-
phoresis and a cross-linking reagent was added to stabilize the
assembled dimers during SDS-PAGE. As a control, the protein
was also incubated without heme and in the presence of 250 mM
SDS, which prevents dimerization. As can be seen in Fig. 1B, a
significant amount of the PsbF fusion protein forms homodimers
in vitro but the presence of either reduced or oxidized heme does
not appear to have any significant effect on dimerization of the
fusion protein as can be deduced from the intensity of the mono-
mer and dimer bands on Coomassie stained gels.
To elucidate any influence of the largeMalE fusion domain on
dimerization and since the SDS-PAGE approach provides only a
rough estimate of the influence of heme binding on oligomeri-
zation, chemically synthesized peptideswere used to further study
dimerization in more detail by resonance energy transfer.
3.2. Synthesis and in vitro reconstitution
For the present study several ways to assemble cytochrome
b559′ from chemically synthesized PbsF peptides in detergent so-
lutionswere tested. Amixture ofDDMand SDS at amole fraction
of around 0.4 (5 mM DDM and 4 mM SDS) resulted in best
assembly of cytochrome b559′ . In Fig. 2 a spectrum of reduced ande GALLEX assay. β-galactosidase activities of three independent measurements
83I) and a strong (wt) interaction tendency. Tests for membrane insertion of the
Urea SDS-PAGE of glutaraldehyde cross-linked PsbF in micelles. 20 mM PsbF-
2 h in the absence (A), or presence of oxidized (B) or reduced heme (C). After
ls containing 6 M urea. The size of the monomer and dimer of PsbF is indicated.
r formation (D). MW: molecular weight.
Fig. 2. Absorbance spectrum of in vitro reconstituted cytochrome b559′ in
reduced (solid line) and oxidized (dotted line) form. 1.5 μM of heme dissolved
in 50 mM Tris pH 8.0, 50 mM NaCl, 5 mM DDM, 3.5 mM SDS was added to
3 μM of the peptide dissolved in the same buffer. The air oxidized sample was
reduced by addition of 5 mM sodium dithionite. Spectra were taken on a Perkin-
Elmer Lambda 25 spectrophotometer with a resolution of 0.5 nm and a scan
speed of 240 nm/min.
Fig. 3. Competition experiments with chemically synthesized PsbF peptides and
a PsbF-MalE fusion protein. The fusion protein was expressed and purified as
described [38]. 3 μg of the PsbF-MalE fusion protein was separated on a 10%
SDS gel (A), or was mixed with a ten-fold molar excess of unlabeled (B), of
BODIPY labeled (C), or of DY-633 labeled peptide (D). The sample was
allowed to equilibrate at room temperature for 2 h and was subsequently
separated on a 10% SDS-gel. MW: molecular weight marker. Molecular weights
in kDa are indicated on the left.
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Formation of cytochrome b559′ , which displays defined absor-
bance maxima, suggests that the monomeric PsbF peptide can
form a homodimer in vitro and binds the heme cofactor.
For measuring oligomerization of chemically synthesized
PsbF peptides in vitro, different PsbF variants were produced,
each labeled with a fluorescent dye, in order to monitor asso-
ciation by fluorescence resonance energy transfer (FRET).
3.3. Specific dimerization of PsbF in micelles
The influence of the site-selectively incorporated fluorophores,
via a single cysteine residue at the C-terminus of the PsbF peptide,
on dimerization of the PsbF transmembrane helix was studied by
competition assays and analyzed by SDS-PAGE. Unlabeled and
labeled peptides were mixed with the PsbF-MalE fusion protein
that forms stable homodimers on SDS-gels (Fig. 3). Addition of
unlabeled peptide results in loss of the dimer band (lane B) as does
addition of the fluorescent labeled peptides (lanes C and D). This
observation suggests that the PsbF helices are able to exchange
with one another and that dye labeling does not significantly
interfere with in vitro dimerization. Surprisingly, we did not ob-
serve a heterodimer between the PsbF-MalE fusion protein and
the peptides on SDS-gels, which has a calculated molecular
weight of 52.5 kDa. Most likely the heterodimer has approxi-
mately the same apparent molecular weight on an SDS gel as the
PsbF-MalE protein alone.
In order to measure energy transfer between the two PsbF
peptides within a homodimer, a fluorescent donor and acceptor
pair was chosen whose absorbance does not overlap with the
inherent absorbance of cytochrome b559′ . This is necessary to
minimize possible interference from absorbance of the cyto-
chrome moiety. BODIPY 577/618 was chosen as a donor fluo-
rophore, since it has a high extinction coefficient and it has been
shown in several studies that BODIPY fluorophores are photo-
stable and relatively insensitive to solvent polarity and pH. In
addition, BODIPY derivatives have already been used to study
interaction of transmembrane helices in vitro [39]. It is worth
noting that the BODIPY fluorophore spectrum can change whenfluorophore monomers are in close proximity to each other
[40,41]. Initially, we attempted to exploit this effect and use
solely BODIPY labeled PsbF to follow oligomerization but we
were not able to observe spectral changes in our steady state
fluorescence measurements, as it has also been reported for the
M13 major coat protein [39]. Therefore, a second peptide was
synthesized that carries the fluorophore DY633 as an acceptor.
The excitation and emission spectra of the BODIPYand DY633
labeled peptides are shown in Fig. 4. Although the absorbance
maximum of BODIPY in buffer is 580 nm, the donor still ab-
sorbs light at wavelengths N590 nm with high efficiency. For all
further experiments the donor was excited at 595 nm. At this
wavelength there is essentially no absorbance from the cyto-
chrome moiety anymore (compare Fig. 2). Nevertheless, the
acceptor dye is also slightly excited at this wavelength. To test
whether fluorescence quenching of BODIPY and/or fluores-
cence emission of DY633 after excitation at 595 nm can be used
to measure energy transfer, the emission spectra of separately
sensitized donor and acceptor peptides were measured, integrat-
ed, and compared to the emission spectrum obtained after mix-
ing of the two populations at a ratio of 1:1 (Fig. 4B). Mixing of
the two differently labeled peptides led to a decrease in donor
fluorescence over a period of 1.5 h whereas the emission of the
acceptor increased (Fig. 4B). Formation of the PsbF hetero-
dimers requires dissociation of the two homodimer populations
and association of the differently labeled peptides, which took
about 1.5 h under the chosen experimental conditions. These
results demonstrate that the two differently labeled peptides can
undergo an exchange reaction with each other and that emis-
sion changes at 628 nm and/or 651 nm can be used to measure
oligomerization of the PsbF peptide by fluorescence quenching
through energy.
It has been shown previously that fluorescence quenching
can be used to analyze the oligomeric structure of single helices
in detergent or lipid vesicles [14,42,43]. The SDS gels shown in
Figs. 1 and 3 demonstrate that PsbF forms homodimers in SDS.
Fig. 5. PsbF association in micelles. Fluorescence quenching at 628 nm is
plotted as a function of the acceptor mole fraction. The total peptide
concentration was kept constant at 4 μM, while the ratio of PsbF-BODIPY
and PsbF-DY633 was varied.
Fig. 4. (A) Fluorescence spectra of labeled PsbF peptides in detergent (PsbF-
BODIPY and PsbF-DY633). Excitation (solid lines) and emission spectra
(dotted lines) were taken at a peptide concentration of 2 μM with excitation
λex=595 nm and emission λem=660 nm. (B) Fluorescence emission was
measured at λex=595 nm for the donor and acceptor peptide alone at a
concentration of 2 μM peptide and the two individual spectra were integrated
(dotted line). An equimolar mixture of donor and acceptor peptides at a total
peptide concentration of 4 μM was incubated at room temperature for 2 h and
fluorescence emission was measured subsequently (solid line).
1819T. Volkmer et al. / Biochimica et Biophysica Acta 1758 (2006) 1815–1822The dependence of energy transfer between the two dyes on the
mole fraction acceptor can be used to determine the number of
peptides associated within an oligomer. In Fig. 5 fluorescence
quenching at 628 nm is displayed as a function of acceptor mole
ratio at a constant total peptide concentration and a constant
peptide to detergent ratio. The data have been fitted with a least
square method. The energy transfer depends linearly on the ac-
ceptor mole fraction and this clearly indicates that the oligomer
formed is a dimer. As derived in [14], the amount of quenched
donor is proportional to 1− (PPsbF-BODIPY)n−1, where PPsbF-BODIPY
is the mole ratio of BODIPY labeled peptide and n is the olig-
omer number. For this calculation, equal energy transfer to all
subunits was assumed. This assumption does not allow to deter-
mine the accurate oligomeric state of larger oligomers but does
permit distinguishing between dimers and higher oligomers,
since the dimer is the only case where quenching vs. mole frac-
tion acceptor is always linear [14,43]. Therefore, it can be con-
cluded that PsbF forms a dimer in micelles (Fig. 5). This
conclusion is consistent with the observation that PsbF also
forms dimers on SDS gels (compare Figs. 1 and 3) and no higher
ordered oligomers were observed.This fluorescence assay provides a valuable tool for testing
the influence of cofactor binding on helix–helix interactions
between PsbF monomers. Any changes in helix–helix interac-
tion should result in increased or decreased FRET and thus can
be e.g. measured as fluorescence quenching at 628 nm.
3.4. Heme binding, the heme redox state, and helix–helix
interactions
In a recent study it was shown that formation of holo-cyto-
chrome b559′ is a three step process [38]: after integration of the
polypeptide into a membrane (step I), the helices interact to form
the homodimeric apo-cytochrome (step II) and subsequently the
cofactor is bound (step III). Cytochrome b559′ formation can
therefore be described with the following scheme:
membrane insertionY2M Y
KD1
½D þ H Y
KD2
½DH  ð1Þ
For the formation of holo-cytochrome b559′ two dissociation
constants have to be considered (KD1 and KD2). So far we only
measured energy transfer caused by dimerization of the mono-
meric PsbF peptides without cofactor, which is described by
KD1.
In principle, measuring the energy transfer between differ-
entially labeled transmembrane helices at various peptide con-
centrations allows determination of the dissociation constant of
transmembrane helices in vitro [42,44,45]. Thus, measuring
FRET at various concentrations of labeled PsbF protein should
allow determination of the PsbF dissociation constant KD1 in
detergent if the dissociation constant of the PsbF peptide is
sufficiently low. However, due to the fact that the labeled PsbF
peptide cannot be dissolved in buffer at concentrations >5 μM,
which appeared to be below theKD1, we were not able to obtain a
sufficient complete titration curve and to subsequently deter-
mine KD1. It can only be estimated that KD1 is >5 μM (data not
shown).
After addition of heme to the PsbF peptide a spectrum typical
for cytochrome b559′ can be measured, which proves that heme is
incorporated into the homodimeric apo-cytochrome b559′ ([D] in
Scheme 1) and, therefore, after addition of heme the equilibrium
is shifted to the holo-form ([DH] in Scheme 1). If addition of
Fig. 6. Effect of heme binding on PsbF dimerization. Donor and acceptor
peptides were mixed in a 1:1 ratio at a total protein concentration of 4 μM and
equilibrated for 2 h at 25 °C. Fluorescence emission spectra were recorded in the
absence of heme (solid line), in the presence of 2 μM heme under air-oxidizing
conditions (dashed line), or in the presence of 2 μM heme and 2 mM sodium
dithionite, which keeps the heme in its reduced form (dotted line). To check
whether oxygen or sodium dithionite has any effect on the emission spectra of
the dyes, emission spectra for each dye were recorded in air saturated buffer,
after purging the samples with argon to keep the sample free of oxygen, and in
the presence of sodium dithionite (data not shown). No differences in
fluorescence emission have been observed under these three experimental
conditions.
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is formed, this can be followed by FRET. As can be seen in
Fig. 6, after addition of heme the donor fluorescence at 628 nm
decreases only marginally, which indicates that binding of heme
only slightly increases dimerization, if at all. By using the
GALLEX approach, we could show that the wt PsbF peptide
dimerizes within a membrane (see above). In addition, after
substitution of the axial heme ligand histidine 36 by alanine,
essentially the same tendency to interact was measured in the
membrane when compared to the wt PsbF protein [38]. This
observation is in good agreement with the further result that
addition of heme does not cause a strong increase of BODIPY
quenching and, therefore, does not result in a dramatic increase
of PsbF dimer formation.
It is possible that the equilibrium described by KD2 does
not only depend on the concentration of the homodimeric apo-
cytochrome [D] and free heme [H] but also on the redox state of
the heme cofactor. PsbF dimer stabilization or destabilization,
depending on the heme redox state, could result in increased or
decreased donor fluorescence quenching.As can be seen in Fig. 6,
we did not observe any significant influence of the heme redox
state on fluorescence quenching. Incorporation of either oxidized
or reduced heme increases helix dimerization to the same extent.
Therefore we conclude that neither the heme redox state nor
heme binding drives cytochrome b559′ formation in vitro, but
cytochrome formation is mainly driven by the interaction of the
transmembrane helices.
4. Discussion
So far not much is know about the in vivo assembly of b-type
cytochromes and even less about the influence of transmem-
brane helix–helix interactions and cofactor binding on trans-
membrane b-type cytochrome assembly.In the recent years, peptide based models have been used to
extensively study in vitro assembly of designed b-type cytochromes
and these studies have allowed to gain insights into structural
requirements for the formation of b-type cytochromes (for recent
reviews see [46,47]. However, always idealized proteins have been
used, which were derived from a transmembrane b-type cyto-
chrome and converted to a soluble protein. Although such an
approach is of great value for studying assembly of idealized
soluble b-type cytochromes, cautionmust be applied in transferring
these finding on transmembrane b-type cytochromes since the
forces, that drive folding and assembly of α-helical transmembrane
proteins, are different. Besides using peptide based models,
assembly of several soluble b-type cytochromes has been studied
to some extend and the influence of heme binding and the heme
redox state on assembly and stability of these proteins has been
analyzed [48,49].
Here we present an analysis of the in vitro assembly of a
transmembrane b-type cytochrome and analyze the influence of
heme binding and the heme redox state on assembly of aminimal
transmembrane b-type cytochrome. The PsbF homodimer dis-
plays a rather simple architecture with only two helices forming
a transmembrane helix dimer and the protein can serve as an
excellent model system to study assembly of a simple transmem-
brane b-type cytochrome. Based on a recent analysis, it has been
suggested that assembly of holo-cytochrome b559′ within the
membrane is a two step process (Scheme 1). In the first step the
PsbF monomers interact to form an apo-cytochrome and in the
second step the heme cofactor binds [38]. In contrast to soluble
proteins, formation of a hydrophobic core is not a driving force
for membrane protein folding, since the membrane (or micel-
lar) environment is hydrophobic. Also no special hydrophobic
pocket has to form to accommodate the cofactors and there is no
need to highly rearrange the structure for heme incorporation or
binding, at least in the case of the apo-cytochrome b559′ homo-
dimer. But does heme binding promote or disturb dimerization
of the PsbF peptides? For cytochrome b559′ we did not observe an
influence of the heme binding on the dimerization propensity of
the PsbF protein. By using a genetic approach, we could show
that the wt PsbF peptide dimerizes within a membrane (Fig. 1A
and [38]). In addition, after substitution of the axial heme ligand
histidine 36 by alanine, essentially the same tendency to interact
was measured in the membrane when compared to the wild-type
PsbF protein. Since replacement of histidine 36 abolishes heme
binding to the apo-cytochrome [38], heme binding appears not to
significantly influence dimerization of the PsbF transmembrane
domain. This observation is in good agreement with the results
obtained with the PsbF-MalE fusion protein (Fig. 1B) and with
the chemically synthesized peptides. Addition of heme does not
result in a significant increase in dimerization, followed on SDS
gels or measured as BODIPY quenching (Fig. 6).
Nevertheless, it has to be mentioned that coupling of a fluo-
rescent dye to a peptide can in general result in interference of
the label with the protein structure. The results presented in
Fig. 3 indicate that the dyes do not significantly interfere with
the in vitro dimerization but we cannot exclude that the fluoro-
phores may have a limited effect on in vitro oligomerization
of the peptide. It is even possible that dye labeling of the PsbF
1821T. Volkmer et al. / Biochimica et Biophysica Acta 1758 (2006) 1815–1822peptide abolishes formation of potential higher ordered struc-
tures and because of this only dimers were observed (Fig. 5). If
this is true, the pathway of cytochrome b559′ formation could be
different in vivo. But it is reassuring that the results from the
genetic approach and the SDS-PAGE approach (Fig. 1) as well
as the FRET data are conclusive and indicate the same pathway
of cytochrome b559′ formation.
Assembly of the holo-cytochrome is mainly driven by trans-
membrane helix interactions and heme binding does not notably
shift the individual assembly steps (Scheme 1) towards a di-
meric state. In contrast to cytochromes with a more complex
structure, in the case of cytochrome b559′ the heme is not deeply
buried within a protein core but is still accessible to detergent or
membrane lipids. This could lead to an entirely different effect
of heme incorporation on the assembly of this transmembrane
b-type cytochrome, when compared to formation and stability
of larger transmembrane helix bundles. Furthermore, partition-
ing of the heme group out of a more hydrophilic environment
into the hydrophobic protein core is most likely also not a
driving force for the assembly of cytochrome b559′ and, more in
general, of transmembrane b-type cytochromes.
A thermodynamic study on the energetics of heme binding to
the soluble cytochrome b562 has shown that heme binding sig-
nificantly contributes to the stability of the holo-protein [50].
This observation indicates that the heme redox state can influ-
ence formation of soluble b-type cytochromes significantly. In
contrast, the data obtained with the SDS-PAGE assay (Fig. 1B)
as well as the FRET study (Fig. 6) suggest that the heme redox
state does not affect dimerization of the PsbF peptide. The mo-
nomer–dimer equilibrium is not highly affected by the formation
of holo-cytochrome b559′ and heme binding does not promote
dimerization of PsbF. Therefore, helix–helix interactions mainly
drive assembly of cytochrome b559′ .
As a conclusion, the observations of this study suggest im-
portant differences between assembly of soluble and transmem-
brane b-type cytochromes. Nevertheless, since cytochrome b559′
displays a rather simple architecture when compared to other b-
type cytochromes, there should be extreme caution in extrap-
olating this study's findings in the folding of other transmem-
brane b-type cytochromes with a more complex structure.
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